🔗 Permalink

Inventor profile of:

Eric Tartour

City:

Paris

Country:

France

Published Applications:

Last publication date:

2024-02-01

Top Assignees for applications by Eric Tartour

The entities that hold a legal rights for patent applications filed by inventor Tartour Eric:

Institut Curie 6 Paris, France
Assistance Publique-Hopitaux De Paris 5 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 4 PARIS, France
UNIVERSITE PARIS DESCARTES 3 Paris, France
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 2 Paris Cedex 13, France
Institut National de la Sante et de la Recherche Medicale 2 Paris, France
UNIVERSITE RENE DESCARTES PARIS 5 2 Paris, France
UNIVERSITE PIERRE ET MARIE CURIE (PARIS VI) 2 Paris, France
Centre National de la Recherche Scientifique (CNRS 2 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 2 Paris Cedex 16, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 1 Paris, France
INSTITUTE CURIE 1 Paris Cedex, France
UNIVERSITE RENE DESCARTES PARIS 5 1 Paris Cedex 06, France
INSTITUTE CURIE 1 Paris, France
Institut Pasteur 1 Paris, France
UNIVERSITE PARIS CITE 1 Paris, France
COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (CEA) 1 Paris, France
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 1 Paris Cedex, France
APHP (ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS) 1 Paris, France
CYTUNE PHARMA 1 Nantes, France
UNIVERSITE DE PARIS 1 Paris, France
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE- INSERM 1 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFQUE 1 Paris, France
UNIVERSITE PIERRE ET MARIE CURIE (PARIS VI) 1 PARIS CEDEX, France
INSTITUT CURIE 1 Paris Cedex 5, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) 1 Paris Cedex 16, France

Recent patent applications by Tartour Eric

Eric Tartour from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-02-01

US20240033366A1

Human necessities

FUNCTIONALIZED SHIGA TOXIN B-SUBUNIT (STxB) PROTEINS AND CONJUGATES THEREOF

#2 | 2023-08-24

US20230266332A1

Physics

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING A CANCER

#3 | 2022-06-23

US20220193199A1

Human necessities

IL-15 AND IL-15RALPHA SUSHI DOMAIN BASED MODULOKINES

#4 | 2022-04-07

US20220107323A1

Physics

METHODS AND COMPOSITIONS FOR IDENTIFYING WHETHER A SUBJECT SUFFERING FROM A CANCER WILL ACHIEVE A RESPONSE WITH AN IMMUNE-CHECKPOINT INHIBITOR

#5 | 2021-10-14

US20210317165A1

Chemistry; metallurgy

ZP3 FRAGMENTS IN IMMUNOTHERAPY OF OVARIAN CANCER

#6 | 2020-08-20

US20200264165A1

Physics

USE OF PD-1 AND TIM-3 AS A MEASURE FOR CD8+ CELLS IN PREDICTING AND TREATING RENAL CELL CARCINOMA

#7 | 2019-07-04

US20190201480A1

Human necessities

COMBINED VACCINATION/RADIOTERAPY FOR CANCER TREATMENT

#8 | 2018-02-08

US20180036368A1

Human necessities

COMBINED VACCINATION/RADIOTERAPY FOR CANCER TREATMENT

#9 | 2017-02-16

US20170042994A1

Human necessities

COMPOSITIONS HAVING MEANS FOR TARGETING AT LEAST ONE ANTIGEN TO DENDRITIC CELLS

#10 | 2016-06-23

US20160175459A1

Human necessities

IL-15 and IL-15RAPLHA sushi domain based immunocytokines

#11 | 2015-02-12

US20150045536A1

Human necessities

Universal carrier for targeting molecules to GB3 receptor expressing cells

#12 | 2014-07-24

US20140205630A1

Human necessities

COMPOSITIONS COMPRISING A B SUBUNIT OF SHIGA TOXIN AND A MEANS STIMULATING NKT CELLS

#13 | 2014-07-17

US20140199379A1

Human necessities

COMPOSITIONS HAVING MEANS FOR TARGETING AT LEAST ONE ANTIGEN TO DENDRITIC CELLS

#14 | 2010-08-05

US20100196418A1

Human necessities

Universal carrier for targeting molecules to Gb3 receptor expressing cells

#15 | 2010-08-05

US20100196417A1

Human necessities

Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cells

#16 | 2010-06-03

US20100138938A1

Human necessities

METHOD OF PRODUCING A MULTICHIMERIC MOUSE AND APPLICATIONS TO STUDY THE IMMUNOPATHOGENESIS OF HUMAN TISSUE-SPECIFIC PATHOLOGIES

#17 | 2009-12-15

US10628415

Universal carrier for targeting molecules to Gb3 receptor expressing cells

InventorID:

838897 ⎘